The NICE guidelines recommend initiation with human neutral protamine Hagedorn (NPH) insulin, whereas long-acting basal insulin has been suggested for patients with a higher risk of developing hypoglycemia, and in circumstances where twice-daily injection may be burdensome [46]. Here, INS is linked to Hypoglycemia.